8-K filing — Endovia Health Sciences, Inc. (SBEV)
Filed: 2026-08-26 AccNo: 0001731122-26-001152 Size: 353 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Read original at edgarStocks · News reference
Splash Beverage Collaborates With Lupvindol To Advance CannEpil As Potential FDA-Regulated Veterinary Pharma Product For Companion-Animal Oncology And Chronic Pain Management
Collaboration with Lupvindol Biosciences will initially target companion-animal oncology and chronic pain managementSplash retains ownership of resulting data, intellectual property and commercialization rightsFORT
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 5, 2026, 12:38 PM
- Checked
- Aug 5, 2026, 12:38 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
8-K filing — SPLASH BEVERAGE GROUP, INC. (SBEV)
Filed: 2026-08-21 AccNo: 0001731122-26-001120 Size: 206 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgarSplash Beverage Group Announces Name Change To Endovia Health Sciences And NYSE American Ticker Change To 'EDVA', Effective August 24
Read original at benzingaSplash Beverage Group Q2 EPS $(0.77) Up From $(17.88) YoY, Sales $0.00, Same YoY
Splash Beverage Group (AMEX:SBEV) reported quarterly losses of $(0.77) per share. This is a 95.69 percent increase over losses of $(17.88) per share from the same period last year. The company reported $0.00 in sales
Read original at benzinga